168 related articles for article (PubMed ID: 30014620)
21. Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database.
Lee S; Kim BK; Song K; Park JY; Ahn SH; Kim SU; Han KH; Kim DY;
J Gastroenterol Hepatol; 2016 Apr; 31(4):842-7. PubMed ID: 26513311
[TBL] [Abstract][Full Text] [Related]
22. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.
Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ
Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763
[TBL] [Abstract][Full Text] [Related]
23. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
Chen PH; Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Chao Y; Lin HC; Wu JC
Ann Hepatol; 2013; 12(2):263-73. PubMed ID: 23396738
[TBL] [Abstract][Full Text] [Related]
24. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
[TBL] [Abstract][Full Text] [Related]
25. Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection.
Tsai MC; Yen YH; Chang KC; Hung CH; Chen CH; Lin MT; Hu TH
BMC Cancer; 2019 Dec; 19(1):1169. PubMed ID: 31791275
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Radiofrequency Ablation and Hepatic Resection for the Treatment of Hepatocellular Carcinoma 2 cm or Less.
Huang Y; Shen Q; Bai HX; Wu J; Ma C; Shang Q; Hunt SJ; Karakousis G; Zhang PJ; Zhang Z
J Vasc Interv Radiol; 2018 Sep; 29(9):1218-1225.e2. PubMed ID: 30075975
[TBL] [Abstract][Full Text] [Related]
27. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC
J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396
[TBL] [Abstract][Full Text] [Related]
28. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
[TBL] [Abstract][Full Text] [Related]
29. Survival of hepatocellular carcinoma patients is significantly improving: a population-based study from southern Switzerland.
Bordoni A; Cerny A; Bihl F; Alerci M; Mazzola P; Peverelli S; Marini G; Majno P; Mazzucchelli L; Spitale A
Cancer Epidemiol; 2014 Dec; 38(6):679-85. PubMed ID: 25454980
[TBL] [Abstract][Full Text] [Related]
30. Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.
Wu CY; Chen YJ; Ho HJ; Hsu YC; Kuo KN; Wu MS; Lin JT
JAMA; 2012 Nov; 308(18):1906-14. PubMed ID: 23162861
[TBL] [Abstract][Full Text] [Related]
31. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival of patients undergoing liver resection for very large hepatocellular carcinomas.
Chang YJ; Chung KP; Chang YJ; Chen LJ
Br J Surg; 2016 Oct; 103(11):1513-20. PubMed ID: 27550624
[TBL] [Abstract][Full Text] [Related]
33. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
34. Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
Kodama K; Kawaguchi T; Hyogo H; Nakajima T; Ono M; Seike M; Takahashi H; Nozaki Y; Kawanaka M; Tanaka S; Imajo K; Sumida Y; Kamada Y; Fujii H; Seko Y; Takehara T; Itoh Y; Nakajima A; Masaki N; Torimura T; Saibara T; Karino Y; Chayama K; Tokushige K
J Gastroenterol Hepatol; 2019 Sep; 34(9):1626-1632. PubMed ID: 30668889
[TBL] [Abstract][Full Text] [Related]
35. [A clinicopathological and prognostic study of rare pathological subtype cases of hepatocellular carcinoma].
Li Z; Bi X; Yang L; Zhao J; Zhao H; Huang Z; Cai J; Zheng X
Zhonghua Wai Ke Za Zhi; 2014 May; 52(5):329-32. PubMed ID: 25034737
[TBL] [Abstract][Full Text] [Related]
36. Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.
Andreou A; Struecker B; Raschzok N; Krenzien F; Haber P; Wabitsch S; Waldbaur C; Touet EM; Eichelberg AC; Atanasov G; Biebl M; Bahra M; Öllinger R; Schmelzle M; Pratschke J
Surg Oncol; 2018 Dec; 27(4):751-758. PubMed ID: 30449503
[TBL] [Abstract][Full Text] [Related]
37. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
38. Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.
Kaibori M; Yoshii K; Hasegawa K; Ogawa A; Kubo S; Tateishi R; Izumi N; Kadoya M; Kudo M; Kumada T; Sakamoto M; Nakashima O; Matsuyama Y; Takayama T; Kokudo N;
Ann Surg; 2019 Jul; 270(1):121-130. PubMed ID: 29608544
[TBL] [Abstract][Full Text] [Related]
39. Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
Pérez P; Rodríguez-Perálvarez M; Guerrero L; González V; Sánchez R; Centeno M; Poyato A; Briceño J; Sánchez-Frías M; Montero JL; De la Mata M
PLoS One; 2017; 12(4):e0175010. PubMed ID: 28403219
[TBL] [Abstract][Full Text] [Related]
40. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
